Effectiveness of sucroferric oxyhydroxide in patients on on-line hemodiafiltration in real

A six-month retrospective study of 42 patients on online hemodiafiltration who switched to sucroferric oxyhydroxide. The data, collected by Aníbal Ferreira of Hospital Curry Cabral, tracks monthly serum phosphorus levels, pill burden, and intravenous iron medication. It shows a 67% reduction in prescribed pills per day after the treatment switch.

Use Cases

• Analyzing the relationship between pill burden reduction and serum phosphorus control based on the monthly treatment data.
• Modeling treatment adherence outcomes based on the frequency of pill intake data collected.
• Comparing the effectiveness of different phosphate binders based on the before-after study design described.

Strengths

• Data is from a multicenter study, suggesting a multi-site patient cohort.
• Includes specific quantitative results, such as a 67% reduction in pills per day and an increase from 33.3% to 45% of patients achieving target phosphorus levels.
• Tracks key clinical variables monthly over a six-month period.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect temporal or source bias inherent to paperswithcode.

Provenance

Source

Aníbal Ferreira, Hospital Curry Cabral

Collection Method

A multicenter, quantitative, retrospective, before-after study conducted as part of routine care.

Time Range

Six-month treatment and follow-up period.